Avalyn Pharma
高管
查看带有其 17 名主要高管的组织结构图
Avalyn Pharma 搜索最多的简介
高管在Avalyn Pharma变化
- Douglas Carlson已作为Chief Financial Officer and Chief Business Officer加入公司 (新闻发布的2024五月2号).
- Craig Conoscenti已作为Senior Vice President, Clinical Development加入公司 (新闻发布的2023十一月7号).
- Jim Bishop已作为Senior Vice President, Business Operations加入公司 (新闻发布的2023十一月7号).
创建提醒
跟踪 Avalyn Pharma 的高管变动
生物技术
Avalyn Pharma 拥有 2,285 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
- WindRose Health Investors has announced the acquisition of SubjectWell (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
Avalyn Pharma 的最新新闻稿
- Avalyn to Participate in Leerink Partners Global Biopharma Conference
- Avalyn Strengthens Leadership Team with Key Appointments, including Dr. Craig Conoscenti as SVP, Clinical Development, and Jim Bishop as SVP, Business Operations
- Avalyn Presents Data from its AP01 and AP02 Inhaled Therapeutics Programs for Pulmonary Fibrosis
- Avalyn to Participate in the 2023 RBC Capital Markets Healthcare Private Company Conference
- Avalyn to Participate in Multiple Upcoming Investor Conferences
- News - Avalyn Pharma Inc
- Events - Avalyn Pharma Inc
- Avalyn Pharma Invited to Participate in the Annual Evercore ISI HealthCONx Conference
- Avalyn Pharma Reports Update in Ongoing Idiopathic Pulmonary Fibrosis Trial
- Avalyn Pharma Appoints Lyn Baranowski Chief Executive Officer
- View more press releases Close
通过电子邮件
